Description: Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia. The company develops, produces, and sells mobile health applications. Its products include wheezo, an electronic wheeze detection tool to detect wheeze in children; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited is based in Melbourne, Australia.
Home Page: respiri.co
432 St Kilda Road
Melbourne,
VIC
3004
Australia
Phone:
61 3 9653 9160
Officers
| Name | Title |
|---|---|
| Mr. Nicholas Smedley | Exec. Chairman |
| Mr. Marjan Mikel B.Sc., M.A.I.C.D. | CEO, MD & Exec. Director |
| Mr. George Vlachodimitropoulos | Chief Technology Officer |
| Mr. Theo Antonopoulos | Chief Commercial Officer |
| Mr. Andrew Metcalfe CPA | Company Sec. |
| Prof. Noam Gavriely | Medical & Scientific Advisor |
| Mr. Simon Godfrey | Medical & Scientific Advisor |
| Mr. Philippe Ludekens | Gen. Mang. of Commercial Operations |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 9.1597 |
| Price-to-Sales TTM: | 28.0154 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |